BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19000655)

  • 1. Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein.
    Saravia C; Martinez P; Granados DS; Lopez C; Reyes C; Patarroyo MA
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1279-83. PubMed ID: 19000655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein.
    Ntumngia FB; Adams JH
    Clin Vaccine Immunol; 2012 Jan; 19(1):30-6. PubMed ID: 22116684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
    Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
    J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission.
    Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND
    Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
    George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
    mSphere; 2019 May; 4(3):. PubMed ID: 31092602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing ABRA protein peptide to fit into the HLA-DRbeta1*0301 molecule renders it protection-inducing.
    Salazar LM; Alba MP; Curtidor H; Bermúdez A; Luis E Vargas ; Rivera ZJ; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Sep; 322(1):119-25. PubMed ID: 15313182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region.
    Kano FS; Sanchez BA; Sousa TN; Tang ML; Saliba J; Oliveira FM; Nogueira PA; Gonçalves AQ; Fontes CJ; Soares IS; Brito CF; Rocha RS; Carvalho LH
    Trop Med Int Health; 2012 Aug; 17(8):989-1000. PubMed ID: 22643072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.
    Ntumngia FB; King CL; Adams JH
    Int J Parasitol; 2012 Nov; 42(12):1055-62. PubMed ID: 23068913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.
    Chen E; Salinas ND; Huang Y; Ntumngia F; Plasencia MD; Gross ML; Adams JH; Tolia NH
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6277-82. PubMed ID: 27194724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fitting modified HRP-I peptide analogue 3D structure into HLA-DR molecules induces protection against Plasmodium falciparum malaria.
    Bermúdez A; Alba P; Espejo F; Vargas LE; Parra C; Rodríguez R; Reyes C; Patarroyo ME
    Int J Biochem Cell Biol; 2005 Feb; 37(2):336-49. PubMed ID: 15474979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein.
    Herrera S; Escobar P; de Plata C; Avila GI; Corradin G; Herrera MA
    J Immunol; 1992 Jun; 148(12):3986-90. PubMed ID: 1376347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying RESA protein peptide 6671 to fit into HLA-DRbeta1* pockets induces protection against malaria.
    Alba MP; Salazar LM; Vargas LE; Trujillo M; Lopez Y; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1154-64. PubMed ID: 14985134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
    Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
    Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.
    Arévalo-Herrera M; Castellanos A; Yazdani SS; Shakri AR; Chitnis CE; Dominik R; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):25-31. PubMed ID: 16291763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple antigen peptides (MAPs) as candidate vaccines against malaria.
    Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G
    Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.
    Rawlinson TA; Barber NM; Mohring F; Cho JS; Kosaisavee V; Gérard SF; Alanine DGW; Labbé GM; Elias SC; Silk SE; Quinkert D; Jin J; Marshall JM; Payne RO; Minassian AM; Russell B; Rénia L; Nosten FH; Moon RW; Higgins MK; Draper SJ
    Nat Microbiol; 2019 Sep; 4(9):1497-1507. PubMed ID: 31133755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antigenicity of universal epitopes from PvDBPII in individuals exposed to Plasmodium vivax malaria.
    Martinez P; Lopez C; Saravia C; Vanegas M; Patarroyo MA
    Microbes Infect; 2010 Dec; 12(14-15):1188-97. PubMed ID: 20804855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.